Disease: Atypical hemolytic uremic syndrome
- [Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy
- A Case of Atypical Hemolytic Uremic Syndrome Triggered by Acute Pancreatitis in a Patient with a Membrane Cofactor Protein (CD46) Genetic Variant
- A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy
- A Complement to Traditional Treatments for Antibody-Mediated Rejection? Use of Eculizumab in Lung Transplantation: A Review and Early Center Experience
- A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
- A Critical Care Standpoint in the Diagnosis of Scleroderma Renal Crisis
- A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS
- A pediatric case of atypical hemolytic uremic syndrome (aHUS): Could any infection play a triggering role?
- A Rare Case of Autoimmune Disorder as a Trigger for Atypical Hemolytic Uremic Syndrome
- Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome
- Adult-onset Still's disease with concurrent thrombotic microangiopathy: Observations from pooled analysis for an uncommon finding
- Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
- Anti-factor B antibodies in atypical hemolytic uremic syndrome
- Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies
- Atypical haemolytic uraemic syndrome in a postpartum patient
- Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints
- Atypical hemolytic uremic syndrome in a child: A rare case report
- Atypical Hemolytic Uremic Syndrome: A Nationwide Colombian Pediatric Series
- Atypical Hemolytic-Uremic Syndrome: Genetic Basis, Clinical Manifestations, and a Multidisciplinary Approach to Management
- Author Response: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome
- Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case report
- Bilateral Retinal Venous Occlusion in Atypical Hemolytic-Uremic Syndrome Due to Complement Factor H Mutation
- C5 inhibition in aHUS
- Campylobacter Colitis as a Trigger for Atypical Hemolytic Uremic Syndrome: About One Case
- Can eculizumab be an option in traditional treatment-resistant ulcerative colitis?
- Cardiac Manifestation in a Child With Atypical Hemolytic Uremic Syndrome
- Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication
- Clinical features of women with thrombotic microangiopathy in pregnancy: A case series from a single Japanese tertiary perinatal care center
- Clinical, Biochemical and Molecular Features of a Cohort of 8 Patients with Inherited Disorders of Vitamin B12 Metabolism in a Metabolic Reference Center
- Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing <em>Escherichia coli</em> O76:H7 from a hemolytic uremic syndrome case and genomic insights from the isolate
- Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing Escherichia coli O76:H7 from a hemolytic uremic syndrome case and genomic insights from the isolate
- Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy
- Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome
- Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome
- Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities
- Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
- Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study
- Concurrent Cobalamin C and Plasminogen Deficiencies in a Patient with Chronic Thrombotic Microangiopathy
- Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review
- De novo atypical hemolytic uremic syndrome associated with C3 gene mutation after kidney transplantation: a rare case of life-threatening diffuse alveolar hemorrhage in an adolescent
- Defective C3d caused by C3 p.W1034R in inherited atypical hemolytic uremic syndrome
- Diacylglycerol kinase-ε is S-palmitoylated on cysteine in the cytoplasmic end of its N-terminal transmembrane fragment
- Diagnosis of Bone Marrow Necrosis following Severe Vaso-Occlusive Crisis in Patient with Compound Heterozygous Sickle Cell Disease
- Diagnostic Challenges and Emerging Pathogeneses of Selected Glomerulopathies
- Diffuse alveolar haemorrhage due to atypical hemolytic uremic syndrome (aHUS) associated with COVID-19
- Eculizumab for pregnancy-related atypical hemolytic uremic syndrome
- Eculizumab Versus Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome: A Systematic Review
- Editors' Note: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome
- Editors' Note: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome
- Efficacy and Safety of Eculizumab in Enteroaggregative <em>E. coli</em> Associated Hemolytic Uremic Syndrome
- Efficacy and Safety of Eculizumab in Enteroaggregative E. coli Associated Hemolytic Uremic Syndrome
- End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision
- Epidemiology, Management, and Outcome of Atypical Hemolytic Uremic Syndrome in an Omani Cohort
- Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study
- Expansion of Anticomplement Therapy Indications from Rare Genetic Disorders to Common Kidney Diseases
- Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD
- Genetic analysis of a child with atypical Hemolytic uremic syndrome and nephrotic-range proteinuria
- Genetic investigation of Nordic patients with complement-mediated kidney diseases
- Hemolytic Uremic Syndrome
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
- Hospital at Home meets need for new dialysis patients
- Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome
- HUS and TTP: traversing the disease and the age spectrum
- Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan
- Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
- Management of pediatric hemolytic uremic syndrome
- Modeling complement activation on human glomerular microvascular endothelial cells
- Narrowing the knowledge gap in atypical HUS
- New findings in preventing recurrence and improving renal function in AHUS patients after renal transplantation treated with eculizumab: a systemic review and meta-analyses
- Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome
- On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
- Ophthalmic manifestations in atypical hemolytic uremic syndrome triggered by intravitreal anti-VEGF
- Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS)
- Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition
- Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report
- Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy
- Plasma Exchange Therapy Using Solvent Detergent-Treated Plasma: An Observational Pilot Study on Complement, Neutrophil and Endothelial Cell Activation in a Case Series of Patients Suffering from Atypical Hemolytic Uremic Syndrome
- Pregnancy-Associated Atypical Hemolytic Uremic Syndrome Successfully Treated with Ravulizumab: A Case Report
- Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with MCP Gene Mutation and Successful Eculizumab Treatment
- Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
- Reader Response: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome
- Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults
- Recurrent disease after pediatric renal transplantation
- Renin and renin blockade have no role in complement activity
- Retraction: Novel Variation in CFB Adult Onset Atypical Hemolytic Uremic Syndrome: A Case Report and Review
- Severe hemolysis, elevated liver enzymes, and low platelet syndrome requiring differentiation of thrombotic microangiopathy: Four cases from a nationwide survey in Japan
- Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused by the heterozygous deletion of CFH in a patient with end-stage kidney disease of uncertain etiology
- Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature
- The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older
- The Rationale of Complement Blockade of the MCP(ggaac) Haplotype following Atypical Hemolytic Uremic Syndrome of Three Southeastern European Countries with a Literature Review
- The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome
- The unanswered question. When to undertake a maternity journey?
- Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology
- Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review
- Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab
- Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
- Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?
- Various phenotypes of postpartum atypical hemolytic uremic syndrome: the role of genetic testing in determining prognosis. Case report
- Voice of a caregiver: call for action for multidisciplinary teams in the care for children with atypical hemolytic uremic syndrome
- What came first, atypical hemolytic uremic syndrome or malignant hypertension: a clinical dilemma